Article Details

Pfizer's Covid Antiviral Paxlovid Target of Enanta Patent Suit - Bloomberg Law

Retrieved on: 2022-06-22 16:52:26

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Covid Antiviral Paxlovid Target of Enanta Patent Suit - Bloomberg Law. View article details on hiswai:

Excerpt

Enanta Pharmaceuticals Inc. alleges that Pfizer Inc.'s Covid-19 antiviral Paxlovid infringes a patent issued last week related to ways to stop a ...

Article found on: news.bloomberglaw.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up